Researchers are looking into whether high doses of famotidine could be used to treat COVID-19 patients.
Business Insider reports that Famotidine is the active ingredient in the heartburn medication Pepcid.
A clinical trial is currently underway, with researchers aiming to recruit 1,200 patients.
The trial is investigating if high doses of famotidine help critically ill coronavirus patients survive.
Researchers are using a dose that's nine times the amount of famotidine typically used to treat heartburn.
Researchers note that there's no evidence yet from the trial that suggests famotidine is helping.